Home / Resource Library / Frontline brentuximab vedotin based therapy for newly diagnosed classical Hodgkin lymphoma: a meta-analysis of randomized controlled trials
Frontline brentuximab vedotin based therapy for newly diagnosed classical Hodgkin lymphoma: a meta-analysis of randomized controlled trials